Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus

Antiviral therapies targeting the pandemic coronavirus disease 2019 (COVID-19) are urgently required. We studied an already-approved botanical drug cepharanthine (CEP) in a cell culture model of GX_P2V, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related virus. RNA-sequencing results showed the virus perturbed the expression of multiple genes including those associated with cellular stress responses such as endoplasmic reticulum (ER) stress and heat shock factor 1 (HSF1)-mediated heat shock response, of which heat shock response-related genes and pathways were at the core. CEP was potent to reverse most dysregulated genes and pathways in infected cells including ER stress/unfolded protein response and HSF1-mediated heat shock response. Additionally, single-cell transcriptomes also confirmed that genes of cellular stress responses and autophagy pathways were enriched in several peripheral blood mononuclear cells populations from COVID-19 patients. In summary, this study uncovered the transcriptome of a SARS-CoV-2-related coronavirus infection model and anti-viral activities of CEP, providing evidence for CEP as a promising therapeutic option for SARS-CoV-2 infection.

[1]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[2]  Erwan L'Her,et al.  Compassionate Use of Remdesivir for Patients with Severe Covid-19 , 2020, The New England journal of medicine.

[3]  M. Y. Kim,et al.  Virus-Heat Shock Protein Interaction and a Novel Axis for Innate Antiviral Immunity , 2012, Cells.

[4]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[5]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[6]  P. Britton,et al.  Involvement of Autophagy in Coronavirus Replication , 2012, Viruses.

[7]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[8]  C. Amici,et al.  NEW EMBO MEMBER’S REVIEW: NF-κB and virus infection: who controls whom , 2003 .

[9]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[10]  P. Giavalisco,et al.  Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics , 2020, bioRxiv.

[11]  K. Fink.  Origin and Function of Circulating Plasmablasts during Acute Viral Infections , 2012, Front. Immun..

[12]  K. Yuen,et al.  Modulation of the Unfolded Protein Response by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2006, Journal of Virology.

[13]  Jia-Fu Jiang,et al.  Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins , 2020, Nature.

[14]  Julio Saez-Rodriguez,et al.  Bringing data from curated pathway resources to Cytoscape with OmniPath , 2019, Bioinform..

[15]  Yi Wang,et al.  Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial , 2020, The Lancet.

[16]  S. S. Chen,et al.  Hepatitis C Virus and Cellular Stress Response: Implications to Molecular Pathogenesis of Liver Diseases , 2012, Viruses.

[17]  Kwok-Hung Chan,et al.  Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial , 2020, The Lancet.

[18]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[19]  Laura J. Simpson,et al.  A single-cell atlas of the peripheral immune response in patients with severe COVID-19 , 2020, Nature Medicine.

[20]  Fabian J Theis,et al.  SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues , 2020, Cell.

[21]  J. Carpenter,et al.  Autophagosome Formation during Varicella-Zoster Virus Infection following Endoplasmic Reticulum Stress and the Unfolded Protein Response , 2011, Journal of Virology.

[22]  Zeyu Chen,et al.  T cell responses in patients with COVID-19 , 2020, Nature Reviews Immunology.

[23]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[24]  Wu Zhong,et al.  Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study , 2020, Engineering.

[25]  Aaron M. Rosenfeld,et al.  Comprehensive mapping of immune perturbations associated with severe COVID-19 , 2020, Science Immunology.

[26]  Jiaming Yu,et al.  Autophagy and Viral Infection , 2019, Advances in experimental medicine and biology.

[27]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. White,et al.  Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase , 2020, bioRxiv : the preprint server for biology.

[29]  Y. Tong,et al.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model , 2020, Chinese medical journal.

[30]  M. Rogosnitzky,et al.  Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions , 2011 .

[31]  N. Gao,et al.  Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network , 2019, Journal of Experimental & Clinical Cancer Research.

[32]  C. Bailly.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications , 2019, Phytomedicine.

[33]  Qingbo Xu,et al.  In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 , 2020, Cell Metabolism.

[34]  Q. Bassat,et al.  Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. , 2020, JAMA network open.

[35]  Catherine Z. Chen,et al.  The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators , 2020, bioRxiv.

[36]  J. Sprent,et al.  Homeostasis of naive and memory T cells. , 2008, Immunity.

[37]  J. Qu,et al.  Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial , 2020, BMJ.

[38]  Kwang Su Kim,et al.  Multidrug treatment with nelfinavir and cepharanthine against COVID-19 , 2020, bioRxiv.

[39]  Xu Jia,et al.  SARS‐CoV‐2 and SARS‐CoV: Virtual screening of potential inhibitors targeting RNA‐dependent RNA polymerase activity (NSP12) , 2020, Journal of medical virology.

[40]  S. Ciesek,et al.  Proteomics of SARS-CoV-2-infected host cells reveals therapy targets , 2020, Nature.

[41]  T. Fung,et al.  Regulation of Stress Responses and Translational Control by Coronavirus , 2016, Viruses.

[42]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[43]  K. To,et al.  Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients , 2020, Cell Research.

[44]  S. Howard,et al.  Drug Repositioning Suggests a Role for the Heat Shock Protein 90 Inhibitor Geldanamycin in Treating COVID-19 Infection , 2020 .

[45]  Younho Choi,et al.  Autophagy during viral infection — a double-edged sword , 2018, Nature Reviews Microbiology.

[46]  D. Raoult,et al.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial , 2020, International Journal of Antimicrobial Agents.

[47]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[48]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.